Table2 Clinical characteristics of pancreatic cancer patients in the PUMCH cohort
Variables | Total | KRT7 Low expression | KRT7 High expression |
|---|---|---|---|
|  | n = 55 (%) | n = 28 (%) | n = 27 (%) |
Age | |||
   < 65 | 28 (50.9) | 16 (57.1) | 12 (44.4) |
   ≥ 65 | 27 (49.1) | 12 (42.9) | 15 (55.6) |
Gender | |||
  Female | 25 (45.5) | 14 (50.0) | 11 (40.7) |
  Male | 30 (54.5) | 14 (50.0) | 16 (59.3) |
Tumor grade | |||
  Well | 4 (7.3) | 2 (7.1) | 2 (7.4) |
  Moderately | 32 (58.2) | 16 (57.1) | 16 (59.3) |
  Poorly | 19 (34.5) | 10 (35.8) | 9 (33.3) |
Stage | |||
  I − IIA | 19 (34.5) | 13 (46.4) | 6 (22.2) |
  IIB − IV | 36 (65.5) | 15 (53.6) | 21 (77.8) |
T | |||
  T1 − T2 | 35 (63.6) | 17 (60.7) | 18 (66.7) |
  T3 − T4 | 20 (36.4) | 11 (39.3) | 9 (33.3) |
N | |||
  N0 | 23 (41.8) | 14 (50.0) | 9 (33.3) |
  N1 − N2 | 32 (58.2) | 14 (50.0) | 18 (66.7) |
M | |||
  M0 | 51 (92.7) | 27 (96.4) | 24 (88.9) |
  M1 | 4 (7.3) | 1 (3.6) | 3 (11.1) |
Status | |||
  Alive | 38 (69.1) | 23 (82.1) | 15 (55.6) |
  Dead | 17 (30.9) | 5 (17.9) | 12 (44.4) |
OS time (months) | |||
  Median (range) | 15 (3 − 38) | 15 (3 − 36) | 13 (3 − 38) |
KRT7 IHC score | |||
  Median (range) | 6 (1 − 12) | 6 (1 − 6) | 9 (8 − 12) |